Abstract:Autosomal dominant polycystic kidney disease (ADPKD) is a common inherited renal disease characterized by many fluid‐filled cysts and interstitial fibrosis in the kidneys, leading to chronic renal failure. During cystogenesis the renal tubules undergo extensive structural alterations that are accompanied by altered cellular signalling, directly and/or indirectly regulated by the PKD1 and PKD2 proteins. Since transforming growth factor (TGF)‐β signalling modulates cell proliferation, differentiation, apoptosis, adhesion and migration of various cell types, we studied the activation of this signalling pathway in Pkd1‐mutant mouse models at different stages of the disease. Therefore, we analysed expression of the TGFβ–Smad signalling pathway and its target genes in different Pkd1 mutant mouse models in various stages of polycystic disease. Nuclear accumulation of P‐Smad2 in cyst lining epithelial cells was not observed in the initiation phase but was observed at mild and more advanced stages of PKD. This coincides with mild fibrosis and increased mRNA levels of TGFβ target genes, such as fibronectin, collagen type I, plasminogen activator inhibitor 1 and matrix metalloproteinase‐2. At this stage many interstitial fibroblasts were found around cysts, which also showed nuclear localization for P‐Smad2. However, bone morphogenetic protein (BMP) signalling, which can antagonize TGFβ signalling, is not affected, since nuclear expression of P‐Smad1/5/8 and expression of the BMP target gene, inhibitor of DNA binding/differential‐1 (ID‐1) is not altered compared to wild‐type controls. Also, human kidneys with progressive ADPKD showed increased nuclear localization of P‐Smad2, while in general expression of P‐Smad1/5/8 was weak. These results exclude TGFβ signalling at the initiation of cystogenesis, but indicate an important role during cyst progression and in fibrogenesis of progressive ADPKD. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Down-Regulation Of Pkhd1 Induces Cell Apoptosis Through Pi3k And Nf-Kappa B Pathways

Regulation of Cell Proliferation and Apoptosis Through Fibrocystin-Prosaposin Interaction

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Pkhd1 Gene Silencing May Cause Cell Abnormal Proliferation Through Modulation Of Intracellular Calcium In Autosomal Recessive Polycystic Kidney Disease

Inhibition of Pkhd1 May Cause S-Phase Entry Via Mtor Signaling Pathway

Polycystin-1 Induced Apoptosis and Cell Cycle Arrest in G0/G1 Phase in Cancer Cells

RNA Helicase P68 Inhibits the Transcription and Post-Transcription of Pkd1 in ADPKD

Defects of renal tubular homeostasis and cystogenesis in the Pkhd1 knockout

Protein Kinase A Downregulation Delays the Development and Progression of Polycystic Kidney Disease

Downregulating PKC Δ Provides a PI3K/Akt-independent Survival Signal That Overcomes Apoptotic Signals Generated by C-Src Overexpression

The Effects of Intrinsic Apoptosis on Cystogenesis in PKD1-deficient ADPKD Pig Model.

Inactivating the Ubiquitin Ligase Parkin Suppresses Cell Proliferation and Induces Apoptosis in Human Keloids.

PKHD1 Post‐transcriptionally Modulated by Mir‐365‐1 Inhibits Cell‐cell Adhesion

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model

Regulation of the Viability of Nf1 Deficient Cells by PKC Isoforms

HRD1 prevents apoptosis in renal tubular epithelial cells by mediating eIF2α ubiquitylation and degradation

Regulation of Protein Kinase C Inactivation by Fas-associated Protein with Death Domain

Dual Role of PID1 in Regulating Apoptosis Induced by Distinct Anticancer-Agents Through AKT/Raf-1-dependent Pathway in Hepatocellular Carcinoma

Elevated TGFβ–Smad Signalling in Experimental Pkd1 Models and Human Patients with Polycystic Kidney Disease

PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts